A novel gastrointestinal neuroprosthetic device has been developed to interface with the enteric nervous system, enabling precise neuromodulation of gut motility and metabolism. This bioelectronic medicine breakthrough offers therapeutic potential for gastrointestinal and metabolic disorders by delivering targeted neural stimulation to the 'second brain.' The device's flexibility and biocompatibility represent substantial advances in implantable neuromodulation technology.